WFC Research Update — July 17, 2026
Updated Thesis
Wells Fargo is a diversified U.S. bank operating consumer and commercial banking, corporate and investment banking, and wealth management, supported by a large deposit franchise, a $2.3 trillion asset base, nationwide advisory distribution, and increasingly relevant capital-markets capabilities. Business quality is high but not without legacy constraints: return on equity is 12.6%, gross margin is 64.5%, operating margin is 21.2%, and net margin is 17.5%, while revenue grew 11.3% year over year and earnings grew 16.6% year over year in the most recent quarter.
The investment grade as of this refresh is B — solid business quality. High-tier business, fair-tier valuation with 18.1% upside to $103.38 fair value.
Key Metrics at a Glance
- Revenue growth: +11.3% year over year
- Net margin: 17.5%
- Fair value upside: +18.1% to our estimate of $103
Current price: $87.53
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Wells Fargo & Company remains in our covered universe with a solid-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full WFC research →](/stocks/WFC)